Cooper C. Collins
CIK 1485508 · Chief Strategic Officer · last filed 2025-11-05
Cooper C. Collins is a Chief Strategic Officer who has filed 37 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for TXMD, was dated Nov 5, 2025. Across all open-market trades the lifetime net is −$19.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $133.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$133.1K
2
37
-$19.73M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TXMD | Director | 60,516 | $2.20 | $133.1K | -$2.99M | 24 | 2025-11-05 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Chief Strategic Officer | 2,980,727 | — | — | -$16.74M | 12 | 2014-03-05 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-05 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | TXMD | Exer (M) | +8,500 | $0 | EDGAR |
| 2024-08-26 | TXMD | Buy (P) | +4,094 | $7.1K | EDGAR |
| 2024-08-23 | TXMD | Buy (P) | +1,200 | $2.0K | EDGAR |
| 2023-07-19 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2022-10-03 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2022-08-22 | TXMD | Exer (M) | +1,984 | $0 | EDGAR |
| 2021-11-22 | TXMD | Buy (P) | +1,000,000 | $578.5K | EDGAR |
| 2021-08-19 | TXMD | Buy (P) | +1,000,000 | $725.0K | EDGAR |
| 2021-08-12 | TXMD | Exer (M) | +96,864 | $0 | EDGAR |